XML 55 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Discontinued Operations (Details) - Schedule of Discontinued Operations - Discontinued Operations [Member] - Annoveras [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Discontinued Operations (Details) - Schedule of Discontinued Operations [Line Items]    
Product revenue, net $ (833) $ 80,749
Cost of goods sold 15,640
Gross profit (loss) (833) 65,109
Operating expenses:    
Selling and marketing 75,208
General and administrative 481 11,301
Research and development 4,942
Restructuring charges 6,180
Total operating expenses 481 97,631
Loss from discontinued operations (1,314) (32,522)
Other income (expense):    
Gain on sale of vitaCare 143,384
Gain on ANNOVERA sale 62,031
Loss on the extinguishment of debt (8,380)
Interest expense and other financing costs (36,065)
Expense for accretion of Series A Preferred Stock (16,973)
Loss on disposal of assets (1,150)
Other expense, net (115)
Total other income (expense), net (1,265) 143,997
Loss before from income taxes (2,579) 111,475
Benefit (provision) for income taxes (552)
Net income (loss) from discontinued operations $ (2,579) $ 110,923